Skip to content

The Effect of Assisted Reproductive Technology on Male Sexual Function.

The Correlation Between Assisted Reproductive Technology and Male Erectile Dysfunction.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04338087
Enrollment
734
Registered
2020-04-08
Start date
2017-01-01
Completion date
2020-03-01
Last updated
2020-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Brief summary

Men participating in assisted reproductive technology treatments will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth.

Detailed description

Men participating in fertility will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth. In addition, participants will be questioned regarding marital life, sexual intercourse frequency, medical history and treatments for erectile dysfunction in relevant cases. Thes control group will be comprised of male subjects who did not require fertility treatments to conceive.

Interventions

OTHERQuestionnaire and personal interviews.

Questionnaire and personal interviews.

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Participation in fertility treatments.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
Changes in International index of erectile function scoreFrom recruitment up to 3 years.Changes in International index of erectile function score with a possible score ranging from 0 to 75. The higher the score, the better erectile function is.

Secondary

MeasureTime frameDescription
Sexual intercourse rate.From recruitment up to 3 years.Sexual intercourse rate as measured by the average monthly intercourse rate.
Use of phospho-di-esterase 5 inhibitorsFrom recruitment up to 3 years.Use of phospho-di-esterase 5 inhibitors as measured by the number of men using this medication.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026